-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Revenues history and growth rate from Q2 2023 to Q2 2025.
- Inhibrx Biosciences, Inc. Revenues for the quarter ending June 30, 2025 was $1.3M, a 1200% increase year-over-year.
- Inhibrx Biosciences, Inc. Revenues for the twelve months ending June 30, 2025 was $1.4M.
- Inhibrx Biosciences, Inc. annual Revenues for 2024 was $200K, a 88.9% decline from 2023.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)